Social & QoL Behaviors in Parkinson's Disease

Parkinson Disease Clinical Trial

Official title:

Social Behaviors and Quality of Life in Individuals With Parkinson's Disease

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06385184
• Other study ID #: NCR234859
• Status: Recruiting
• Start date: March 8, 2024
• Est. completion date: December 31, 2025

Study information

• Verified date: April 2024
• Source: George Washington University
• Contact: Gregory Wallace, PhD
• Phone: 202-994-8285
• Email: ladn[@]gwu.edu
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Adults with Parkinson's Disease experience an array of challenges and changes in daily living, behaviors, and functioning throughout the progression of their condition. The investigators want to learn more about the effects of Parkinson's Disease on individuals' social behavior and quality of life (QoL) compared to people of the same age without Parkinson's Disease.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 500
• Est. completion date: December 31, 2025
• Est. primary completion date: December 31, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 40 Years and older

Eligibility

Parkinson's disease group

Inclusion Criteria:

• Have been diagnosed with Parkinsons Disease by a healthcare professional

• Are at least 40 years old

Exclusion Criteria:

• Possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome)

Neurotypical group

Inclusion Criteria:

• Are at least 40 years old

Exclusion Criteria:

• Have been diagnosed with Parkinson's disease by a healthcare professional

• Possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome)

Related Conditions & MeSH terms

• Parkinson Disease

Intervention

Other:
• No Intervention
Observational study with no intervention

Locations

Country	Name	City	State
United States	The George Washington University	Washington	District of Columbia

Sponsors (1)

Lead Sponsor	Collaborator
Gregory Wallace

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Subjective Quality of Life	satisfaction with different aspects of life, such as health and social relationships	through study completion, an average of 1 year
Primary	Social Behavior	ability to interact with others	through study completion, an average of 1 year
Primary	Activities of Daily Living	ability to complete tasks to be independent	through study completion, an average of 1 year
Primary	Mental Health	depression and anxiety symptoms	through study completion, an average of 1 year
Primary	Cognition	memory and executive function challenges and strengths	through study completion, an average of 1 year